Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 2.2B | 2.0B | 1.9B | 1.9B |
Cost of revenue | 1.6B | 1.4B | 1.4B | 1.3B |
Gross profit | 668M | 583M | 527M | 544M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 501M | 482M | 476M | 461M |
Other operating expenses | — | — | — | — |
Operating income | 118M | 50M | 0 | 32M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2M | 2M | 3M | 1M |
Other income expense | -39M | -73M | -11M | -18M |
Pretax income | 77M | -25M | -14M | 13M |
Tax provision | 22M | 8M | -2M | 5M |
Net income | 49M | -33M | -12M | 8M |
Basic EPS | — | -0.3 | -0.1 | 0.1 |
Diluted EPS | — | -0.3 | -0.1 | 0.1 |
Basic average shares | — | 95M | 95M | 94.7M |
Diluted average shares | — | 95M | 95M | 95.3M |
EBITDA | 164M | 101M | 49M | 79M |
Net income from continuing op. | 49M | -33M | -12M | 8M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |